SEC Filing Summary: CNO Financial Group, Inc.
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by CNO Financial Group, Inc. for the reporting period ending June 30, 2016. The document discloses the company's holdings in equity securities and certain debt instruments as of the quarter end. It does not contain operational financial statements for CNO Financial Group itself.
Key Financial Metrics and Holdings
The filing details a portfolio of 19 distinct positions. The total value of reported holdings is approximately $347.5 million (sum of Column 4 values). The portfolio is heavily weighted toward fixed income and broad market ETFs.
- Largest Single Holding: TCP Capital Corp (Common Stock) valued at $30.7 million.
- Fixed Income Exposure: Significant principal amounts in corporate notes, including Bristol-Myers Squibb ($1.0 million), Danaher Corp ($1.0 million), and Wellpoint Inc ($1.5 million).
- ETF Exposure: Major allocations to iShares Core US Aggregate Bond ETF ($118.8 million) and SPDR S&P 500 ETF ($95.4 million).
- Voting Authority: CNO Financial Group reported Sole voting authority for all listed positions.
Material Changes
The filing text provided is a static snapshot of holdings as of June 30, 2016. It does not provide comparative data against the prior quarter (March 31, 2016) or year-over-year figures. Therefore, material changes in position size or portfolio composition cannot be determined from this document alone.
Guidance, Outlook, and Risks
Form 13F filings are regulatory disclosures of holdings and do not contain management commentary, forward-looking guidance, risk factors, or contingency plans. The document includes a standard disclaimer stating that the SEC has not reviewed the information for accuracy or completeness.
Investor Verification Checklist
- Verify the total portfolio value by summing the "Value" column to confirm the approximate $347.5 million aggregate.
- Compare these holdings against the prior quarter's Form 13F to identify new entries or divestitures.
- Review the specific CUSIPs for the fixed income positions (e.g., Bristol-Myers Squibb, Danaher) to confirm maturity dates and interest rates not fully detailed in the summary.
- Confirm that the "Sole" voting authority designation aligns with the company's investment management structure.